UBS Group’s ZyVersa Therapeutics ZVSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.6K | Buy |
39,280
+10,953
| +39% | +$7.42K | ﹤0.01% | 6946 |
|
|
2025
Q1 | $17.8K | Buy |
28,327
+24,140
| +577% | +$15.2K | ﹤0.01% | 7004 |
|
|
2024
Q4 | $4.44K | Buy |
4,187
+3,754
| +867% | +$3.98K | ﹤0.01% | 7512 |
|
|
2024
Q3 | $1.04K | Buy |
+433
| New | +$1.04K | ﹤0.01% | 7520 |
|
|
2024
Q2 | – | Sell |
-1,991
| Closed | -$14.9K | – | 8852 |
|
|
2024
Q1 | $14.9K | Buy |
1,991
+1,664
| +509% | +$12.5K | ﹤0.01% | 5880 |
|
|
2023
Q4 | $2.95K | Buy |
+327
| New | +$2.95K | ﹤0.01% | 6819 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8029 |
|
|
2023
Q2 | – | Sell |
-9
| Closed | -$6.33K | – | 8513 |
|
|
2023
Q1 | $6.33K | Buy |
+9
| New | +$6.33K | ﹤0.01% | 6830 |
|